Dr Carsten Sauerland, currently Chief Executive Officer of HC Trading, a globally operating trading company of HeidelbergCement, will become the new Chief Financial Officer of the PHOENIX group with effect from 1 May 2022. He will succeed Dr Lorenz Näger, who took over the mandate on an interim basis on 24 January 2022 from Helmut Fischer, who is on sick leave. Dr Näger will resume his dormant membership in the Supervisory Board of the PHOENIX group on 1 June 2022.
Dr Carsten Sauerland has held various international positions at HeidelbergCement since 2010. Before taking on the role of CEO of HC Trading, Dr Sauerland was Group Director Reporting, Controlling and Consolidation at HeidelbergCement from 2016 to 2020.
“Dr Sauerland is a competent financial expert with extensive experience in Germany and abroad. We look forward to working with him,” says Dr Bernd Scheifele, Chairman of the Supervisory Board of the PHOENIX group, adding: “On behalf of the shareholders, the Supervisory Board, and the Executive Board, I would like to thank Dr Näger for the excellent collaboration and wish Mr Fischer all the best for his ongoing recovery.”
Sven Seidel, Chief Executive Officer of the PHOENIX group, says: “I would like to extend a warm welcome to Dr Carsten Sauerland on behalf of the entire Executive Board and all our colleagues in the PHOENIX group.”
With pharmaceutical wholesale, pharmacy retail, and other services, the PHOENIX group makes a vital contribution to healthcare in Europe. The leading integrated healthcare provider is active in 26 countries and is market leader in pharmaceutical wholesale in Germany.